Operating Lease, Right-of-Use Asset of Eloxx Pharmaceuticals, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Eloxx Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $0.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Eloxx Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 $0 31 Dec 2025 10-K 17 Mar 2026 2025 FY
Q4 2024 $0 -$129,000 -100% 31 Dec 2024 10-K 17 Mar 2026 2025 FY
Q4 2023 $129,000 -$696,000 -84% 31 Dec 2023 10-K 17 Mar 2026 2025 FY
Q3 2023 $306,000 -$687,000 -69% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $481,000 -$678,000 -58% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $654,000 -$611,000 -48% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $825,000 -$618,000 -43% 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $993,000 -$624,000 -39% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $1,159,000 -$707,000 -38% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,265,000 +$976,000 +338% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $1,443,000 +$1,022,000 +243% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $1,617,000 +$1,066,000 +193% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $1,866,000 +$1,188,000 +175% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $289,000 -$533,000 -65% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $421,000 -$503,000 -54% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $551,000 -$319,000 -37% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $678,000 -$311,000 -31% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $822,000 -$284,000 -26% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $924,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $870,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $989,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,106,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.